Get your full text copy in PDF

Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure

Divya Mirchandani, Rafia Jawed, Nayaab Khawar, Pramod Narula, Minnie John

(Department of Pediatrics, New York Presbyterian Healthcare System – New York Methodist Hospital, Brooklyn, NY, USA)

Am J Case Rep 2017; 18:381-385

DOI: 10.12659/AJCR.902418

BACKGROUND: Liver failure in the neonatal population is a life-threatening complication and has a wide array of etiologies, including infectious, immune-mediated, metabolic, or drug-induced. Although neonatal herpes simplex virus (HSV) hepatitis only accounts for 1% of all acute liver failures, it has an extremely aggressive clinical course that carries a mortality rate of 85%.
CASE REPORT: We report a rare case of disseminated neonatal HSV-2 with late presentation associated with fulminant liver failure. The patient recovered without obvious neurologic deficits or need for liver transplant.
CONCLUSIONS: This case study emphasizes and promotes awareness of early recognition and appropriate clinical management of neonatal HSV infection, and its positive outcome.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

I agree